We performed co-cultures of glioblastoma and healthy donor PBMCs, as previously described [16], to address whether SAFit-mediated PD-L1 down modulation on glioma cells could modulate death of PBMC via tumour-associated PD-L1. The gene discussed is CD274; the disease is central nervous system cancer.